SVB Leerink Starts Johnson & Johnson (JNJ) at Outperform Citing Favorable Financial Strength
Tweet Send to a Friend
SVB Leerink analyst David Risinger initiates coverage on Johnson & Johnson (NYSE: JNJ) with a Outperform rating and a price ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE